<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Tangential-Flow-Filtration on 生物经济</title><link>https://cn.bioecon.ru/technologies/tangential-flow-filtration/</link><description>Recent content in Tangential-Flow-Filtration on 生物经济</description><generator>Hugo</generator><language>zh-CN</language><lastBuildDate>Sun, 26 Jul 2026 12:15:59 +0700</lastBuildDate><atom:link href="https://cn.bioecon.ru/technologies/tangential-flow-filtration/index.xml" rel="self" type="application/rss+xml"/><item><title>mRNA / LNP 制造设备</title><link>https://cn.bioecon.ru/technology/mrna-lnp-manufacturing-equipment/</link><pubDate>Sat, 25 Jul 2026 20:35:00 +0000</pubDate><guid>https://cn.bioecon.ru/technology/mrna-lnp-manufacturing-equipment/</guid><description>将mRNA与四脂乙醇混合液在微秒内汇合并自组装为80–120 nm脂质纳米颗粒的混合器、模块化系统与连续流反应器——支撑每一支商业化mRNA疫苗与新一代基因治疗体内递送系统的硬件层。</description></item><item><title>生物制药下游纯化与生物分离（DSP）</title><link>https://cn.bioecon.ru/technology/downstream-purification-bioseparation/</link><pubDate>Fri, 19 Jun 2026 00:00:00 +0000</pubDate><guid>https://cn.bioecon.ru/technology/downstream-purification-bioseparation/</guid><description>下游纯化将粗制生物反应器收获液转化为临床级原料药——蛋白A层析、切向流过滤和病毒清除合计占生物制造资本支出的&amp;gt;50%。全球DSP市场超过$5B，受单抗和细胞基因治疗需求驱动，年均增速&amp;gt;8%。</description></item></channel></rss>